About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Immune Checkpoint Inhibitors Transforming Cancer Treatment

by Bidita Debnath on October 2, 2017 at 10:02 PM
Font : A-A+

 Immune Checkpoint Inhibitors Transforming Cancer Treatment

Traces of the cancer's DNA in the blood can give clues about which treatments are most likely to work for that patient. The number of alterations detected in the DNA collected from blood samples (liquid biopsies) of cancer patients treated with immune checkpoint inhibitors was associated with response to the treatment.

The study was published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Advertisement


Authors: Senior author: Razelle Kurzrock, MD, director of the Center for Personalized Cancer Therapy at the University of California San Diego Moores Cancer Center; Lead author: Yulian Khagi, MD, a Hematology-Oncology fellow at the University of California San Diego Moores Cancer Center.

"Immune checkpoint inhibitors, a class of immunotherapy, are transforming cancer treatment; however, overall only about 20 percent of patients respond to these drugs, and the drugs sometimes have significant side effects," said Kurzrock. "Therefore, it is important to have biomarkers that can help predict response to these relatively new drugs.
Advertisement

Most biomarkers used to predict response to checkpoint inhibitors are measured on tumor biopsy specimens and have limitations, said Khagi. "Biopsies can be painful, expensive, risky, and not always representative of the tumor characteristics overall," he said. "We wanted to identify an easily obtainable and easily interpretable biomarker that can predict response to checkpoint inhibitor therapy utilizing genomic sequencing of DNA that is shed from cancer cells into the bloodstream."

Using blood samples from 69 patients with different types of cancer treated with immune checkpoint inhibitor therapy, the investigators analyzed the ctDNA by next-generation sequencing (Guardant360 assay). Specifically, they counted the number of variants of unknown significance (VUS, alterations/mutations in the DNA whose association with disease risk is unknown).

Of the 69 patients, 29 percent had more than three VUS alterations and 71 percent had three or fewer VUS in their ctDNA.

After being treated with an immune checkpoint inhibitor, patients with more than three VUS in their ctDNA had significantly higher response rates (45 percent) compared with those who had three or fewer VUS (15 percent).

Among patients who had higher numbers of alterations of the VUS type, the median survival was not reached while those who had lower numbers of alterations of the VUS type had a median survival of only about 11 months.

"Our study demonstrated that high circulating tumor DNA [ctDNA, tumor DNA derived from a blood sample] alteration number was associated with response to checkpoint inhibitor therapy," Kurzrock said.

"Though the study was small, a significant difference could also be identified for a longer survival without progression of cancer and even a longer overall survival in the high versus low VUS alteration group," noted Khagi. "It is likely that, with larger studies, this difference will become more significant."

"Mutations lead to the production of abnormal proteins; the more mutations and abnormal proteins the tumors produce, the better the chance that one or more of these proteins will be 'detected' by the immune system," explained Kurzrock. "We showed that counting the mutations in the DNA floating in the bloodstream could help predict response to these new and exciting drugs that boost the immune system to attack cancer."

Khagi noted, "If verified by further studies, clinicians will be able to utilize the objective results of this simple blood test to make determinations about whether to use checkpoint inhibitor-based immune therapy in a variety of tumor types. It should also be noted that the cutoff points might be different as these blood tests evolve to detect more mutations in more genes."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Sea Buckthorn
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Myasthenia Gravis Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Tumor Lysis Syndrome Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Recommended Reading
Vesicle Formation Findings may Help Develop Liquid Biopsies, Drug Delivery Devices
In biological systems, vesicles bring material in and out of the cell....
Liquid Biopsies Effective To Detect Mutations In Advanced Lung Cancer
Liquid biopsies offer the advantage of testing without discomfort to the patient and possible risks ...
Non-Invasive 'Liquid Biopsies' can Find Prostate Cancer: Research
Research finds that non-invasive 'liquid biopsies' can find metastatic or recurrent prostate ......
Liquid Biopsies Offer Hope for Better Tracking of Ovarian Cancer
Ovarian cancer is a hard-to-detect disease. More than 21,000 women in the U.S. were diagnosed with ....
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Myasthenia Gravis
Myasthenia gravis is the commonest disorder of neuromuscular transmission. Autoimmune myasthenia gra...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Tumor Lysis Syndrome
Tumor lysis syndrome is a collection of metabolic abnormalities due to the tumor cell lysis in patie...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use